FGF9 and metabolic dysfunction-associated steatotic liver disease: To further confirm whether the overexpression of FGF9 inhibits NAFLD development induced by HFD, we generated liver-specific FGF9 transgenic mice (FGF9alb-cre) by crossing Alb-Cre mice and FGF9 Rosa26 knockin mice.